doi:10.1016/j.jcis.2019.03.019 124
monitoring is warranted
CrossRef Association of the Triglyceride-Glucose Index With Established Cardiovascular Disease in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Cross-Sectional Study Soumayan Mondal, Sidharth S Pattnaik, Nihar Ranjan Mohanty, Sailendra Nayak, Ambika Mohanty, Shubhransu Patro Cureus .2026;[Epub] CrossRef Dysregulation of the AMPK-SREBP1-FASN axis in MASLD: driving a vicious cycle of lipotoxicity and metabolic-immune crosstalk Qiqi Zhao, Shengwen Lu, Yu Guan, Zhiwen Sun, Shi Qiu, Aihua Zhang Lipids in Health and Disease .2026;[Epub] CrossRef Prognostic value of non-invasive fibrosis assessment scores in predicting mortality among individuals with metabolic dysfunction-associated steatotic liver disease Lingjie Wu, Shunling Cai, Zhongbin Lin, Ruilie Chen, Yuanfeng Zhang, Xiaobing Gong BMC Public Health .2026;[Epub] CrossRef DapagliflozinAssociated Reduction in Liver Fat Is Independent of Weight Loss in Patients With Type 2 Diabetes Anna V

Depending on client protein conformation and cellular context, HSP70 and HSP90 can either promote refolding into nontoxic states or facilitate clearance through proteasomal or autophagic pathways
The bodys immune system attacks the thyroid gland causing damage to the gland